跳至主要内容
临床试验/NCT00424320
NCT00424320Unknown3 期

Clinical Controlled Trial to Determinate the Role of Sodium Bicarbonate in the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing to Diagnostic Coronariography and/or Percutaneous Coronary Intervention

Instituto Nacional de Cardiologia Ignacio Chavez4 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2006年10月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
发起方
入组人数
100
试验地点
4
主要终点
Contrast-induced nephropathy

研究概览

简要总结

The purpose of this study is to determine whether sodium bicarbonate is effective in the prevention of sodium-induced nephropathy

详细描述

The use of contrast media is more frequent as new diagnostic and therapeutic procedures are developed. As a consequence, the occurrence of acute renal failure (ARF), also known as contrast-induced nephropathy, is more frequently seen after the realization of these procedures, representing about 10% of all in-hospital ARF. The importance of preventing this complication is related with its strong association with higher morbidity and mortality rates in patients who present it. A number of drugs and interventions have been studied for preventing contrast-induced nephropathy, including intravenous hydration with normal and hypotonic saline solutions, oral hydration, mannitol, diuretics, dopamine and its antagonists (fenoldopam), calcium antagonists, theophylline, N-acetylcysteine, natriuretic atrial peptide and hemodialysis after or during contrast media administration.

There is only one study in humans that demonstrates the utility of the sodium bicarbonate to prevent the contrast-induced nephropathy, showing a reduction in the incidence of this complication of about 13.6%. Although this result could seem convincing, its relevance has been questioned because the definition used by the authors as contrast-induced nephropathy was an increase of 25% from basal creatinine. Although when compared, the absolute differences between basal and after-procedure creatinines were not statistically significative, the sample size was small and the participants were low-risk patients to develop contrast-induced nephropathy. It is also important to note that the control group was hydrated with a dextrose 5% solution with 154 mEq of NaCl, although today's most accepted prevention therapy is intravenous hydration with normal saline solution.

Comparison: Hydration previously, during and afterwards contrast media administration with normal saline solution (0.9%), compared to hydration previous, during and afterwards contrast media administration with a solution made of normal saline and sodium bicarbonate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18 years old
  • Indication for coronariography and/or percutaneous coronary intervention
  • Voluntary written consent for the realization of coronariography and/or percutaneous intervention and for the participation in this clinical trial
  • A MEHRAN contrast-induced nephropathy score of six or more

排除标准

  • Patients with chronic kidney failure requiring any kind of dialysis
  • Patients unable to complete follow-up
  • Multiple myeloma
  • Exposure to contrast 48 hours prior to study
  • Pregnancy
  • Patients unable to give consent
  • Already receiving sodium bicarbonate solutions
  • Receiving contrast media other than non-ionic

结局指标

主要结局

Contrast-induced nephropathy

次要结局

  • Hemodialysis

研究者

发起方
Instituto Nacional de Cardiologia Ignacio Chavez
申办方类型
Other

研究点 (4)

Loading locations...

相似试验